Isabel Conde

1.3k total citations
27 papers, 491 citations indexed

About

Isabel Conde is a scholar working on Epidemiology, Hepatology and Pharmacology. According to data from OpenAlex, Isabel Conde has authored 27 papers receiving a total of 491 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Epidemiology, 15 papers in Hepatology and 9 papers in Pharmacology. Recurrent topics in Isabel Conde's work include Liver Disease Diagnosis and Treatment (13 papers), Drug-Induced Hepatotoxicity and Protection (8 papers) and Liver Disease and Transplantation (6 papers). Isabel Conde is often cited by papers focused on Liver Disease Diagnosis and Treatment (13 papers), Drug-Induced Hepatotoxicity and Protection (8 papers) and Liver Disease and Transplantation (6 papers). Isabel Conde collaborates with scholars based in Spain, United States and Uruguay. Isabel Conde's co-authors include Laia Tolosa, M.J. Gómez-Lechón, M. Teresa Donato, José V. Castell, Ramiro Jover, Salvador Benlloch, Alfonso Quintás‐Cardama, Marina Berenguer, Laia Pedrola and María José Gómez‐Lechón and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Analytical Chemistry.

In The Last Decade

Isabel Conde

24 papers receiving 487 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Isabel Conde Spain 12 184 165 158 151 70 27 491
Chitra Kanchagar United States 6 221 1.2× 60 0.4× 166 1.1× 186 1.2× 86 1.2× 8 516
Annelies L. Draaisma Netherlands 8 131 0.7× 89 0.5× 118 0.7× 227 1.5× 21 0.3× 9 565
Esther G. van de Kerkhof Netherlands 6 89 0.5× 68 0.4× 128 0.8× 180 1.2× 25 0.4× 8 551
Nicola Swales United Kingdom 8 159 0.9× 32 0.2× 96 0.6× 162 1.1× 28 0.4× 13 462
D. Runge Germany 12 227 1.2× 67 0.4× 151 1.0× 140 0.9× 32 0.5× 19 508
Susan Grepper United States 7 70 0.4× 46 0.3× 307 1.9× 140 0.9× 37 0.5× 8 545
Joost Boeckmans Belgium 12 125 0.7× 264 1.6× 162 1.0× 27 0.2× 21 0.3× 32 440
Weiguang Ren China 10 92 0.5× 153 0.9× 124 0.8× 31 0.2× 52 0.7× 24 333
Sagnik Chatterjee India 9 189 1.0× 155 0.9× 104 0.7× 188 1.2× 8 0.1× 15 551
Chad Pope United States 7 36 0.2× 101 0.6× 218 1.4× 82 0.5× 133 1.9× 10 491

Countries citing papers authored by Isabel Conde

Since Specialization
Citations

This map shows the geographic impact of Isabel Conde's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Isabel Conde with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Isabel Conde more than expected).

Fields of papers citing papers by Isabel Conde

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Isabel Conde. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Isabel Conde. The network helps show where Isabel Conde may publish in the future.

Co-authorship network of co-authors of Isabel Conde

This figure shows the co-authorship network connecting the top 25 collaborators of Isabel Conde. A scholar is included among the top collaborators of Isabel Conde based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Isabel Conde. Isabel Conde is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Karvellas, Constantine, Florent Artru, Audrey Coilly, et al.. (2025). Management of the Acute Liver Failure Patient and the Role of Liver Transplantation. Transplantation. 109(11). 1680–1691.
2.
Conde, Isabel, Sonia Pascual, Antoni Palau, et al.. (2024). Primary Sclerosing Cholangitis: Gender Effects in Valencia’s Low-Prevalence Region. Digestive Diseases and Sciences. 69(5). 1863–1871.
3.
Gürakar, Ahmet, Isabel Conde, Florent Artru, et al.. (2024). An international, multicenter, survey-based analysis of practice and management of acute liver failure. Liver Transplantation. 30(12). 1217–1225. 3 indexed citations
4.
Vinaixa, Carmen, Isabel Conde, Fernando Díaz‐Fontenla, et al.. (2024). FibroScan compared to liver biopsy for accurately staging recurrent hepatic steatosis and fibrosis after transplantation for MASH. Liver International. 44(12). 3174–3182. 1 indexed citations
5.
García‐Cortés, Miren, Aida Ortega‐Alonso, Inmaculada Medina‐Cáliz, et al.. (2023). Clinical presentation, causative drugs and outcome of patients with autoimmune features in two prospective DILI registries. Liver International. 43(8). 1749–1760. 13 indexed citations
6.
Medina‐Cáliz, Inmaculada, Judith Sanabria‐Cabrera, Marina Villanueva‐Paz, et al.. (2023). Characterization of drug-induced liver injury associated with drug reaction with eosinophilia and systemic symptoms in two prospective DILI registries. Archives of Toxicology. 98(1). 303–325. 4 indexed citations
7.
Fuentes, Francisco Buendía, et al.. (2022). CA125: a new biomarker in patients with Fontan circulation. Revista Española de Cardiología (English Edition). 76(2). 112–120. 3 indexed citations
8.
Fuentes, Francisco Buendía, et al.. (2022). CA125 como nuevo biomarcador en pacientes con circulación de Fontan. Revista Española de Cardiología. 76(2). 112–120.
9.
Quintás‐Cardama, Alfonso, et al.. (2021). Metabolomic analysis to discriminate drug-induced liver injury (DILI) phenotypes. Archives of Toxicology. 95(9). 3049–3062. 30 indexed citations
10.
Conde, Isabel, Tommaso Di Maira, Salvador Peiró, et al.. (2020). A population-based screening for hepatitis C antibodies and active infection using a point-of-care test in a low prevalence area. PLoS ONE. 15(2). e0228351–e0228351. 10 indexed citations
12.
Conde, Isabel, Tommaso Di Maira, Victoria Aguilera, et al.. (2018). Performance of the OraQuick Hepatitis C virus antibody test in oral fluid and fingerstick blood before and after treatment-induced viral clearance. Journal of Clinical Virology. 102. 77–83. 32 indexed citations
13.
Fernández-Murga, María Leonor, Petar Petrov, Isabel Conde, et al.. (2018). Advances in drug-induced cholestasis: Clinical perspectives, potential mechanisms and in vitro systems. Food and Chemical Toxicology. 120. 196–212. 19 indexed citations
14.
Conde, Isabel, Alfonso Quintás‐Cardama, Laia Pedrola, et al.. (2018). Non-invasive prediction of NAFLD severity: a comprehensive, independent validation of previously postulated serum microRNA biomarkers. Scientific Reports. 8(1). 10606–10606. 58 indexed citations
16.
Conde, Isabel, et al.. (2017). Pilot validation study of a rapid test in oral fluid for population screening of hepatitis C virus infection. Journal of Hepatology. 66(1). S403–S404. 2 indexed citations
17.
Conde, Isabel, Carmen Vinaixa, & Marina Berenguer. (2016). Cirrosis por hepatitis C. Estado actual. Medicina Clínica. 148(2). 78–85. 7 indexed citations
18.
Thiel, Christoph, et al.. (2016). Model-based contextualization of in vitro toxicity data quantitatively predicts in vivo drug response in patients. Archives of Toxicology. 91(2). 865–883. 15 indexed citations
19.
Almeida, Alessandra Maciel, Arlindo R. Ferreira, María João Costa, et al.. (2015). 200 CLINICAL OUTCOMES OF AML PATIENTS TREATED WITH AZACITIDINE IN PORTUGAL: A RETROSPECTIVE MULTICENTER STUDY. Leukemia Research. 39. S100–S100. 3 indexed citations
20.
Gómez-Lechón, M.J., Laia Tolosa, Isabel Conde, & M. Teresa Donato. (2014). Competency of different cell models to predict human hepatotoxic drugs. Expert Opinion on Drug Metabolism & Toxicology. 10(11). 1553–1568. 155 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026